HESG Health Sciences Group Inc (CE)

Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative nutraceutical products and functional food ingredients derived from natural sources, announced today that it received a purchase order for Shugr from Value Drug Company. Value Drug Company, incorporated in 1936, is a wholesale purchasing cooperative located in central Pennsylvania. "We are delighted to have received this purchase order from Value Drug," said Fred E. Tannous, co-Chairman and Chief Executive Officer of Health Sciences Group, Inc. "This is a result of our efforts to expand the distribution of Shugr beyond the specialty retail and grocery channels into the drugstore category. Value Drug is a well established and respected purchasing cooperative in the drugstore category, and we look forward to working with them to get Shugr into their cooperative purchasing network." Shugr is the first natural, zero-calorie sweetener made from sugars that occur naturally in such good-tasting, healthy foods as fruits, vegetables, corn and dairy products. Erythritol is a naturally occurring sugar commonly found in melons, grapes, mushrooms and soy. Tagatose comes from dairy products, but does not affect people who are lactose intolerant. Tagatose also provides an added health benefit -- prebiotic fiber that promotes intestinal health, much the way yogurt does. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free. A trace amount of sucralose is added to give Shugr its "high note." All of these ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety from the U.S. Food & Drug Administration. About Value Drug Company Value Drug Company, based in central Pennsylvania, is a wholesale purchasing cooperative. Incorporated in 1936, Value Drug Company has been working with independent pharmacies and drug stores to stay competitive in today's growing market. For more information and to order products, including Shugr(TM), contact 800-252-3786. About Health Sciences Group, Inc. Health Sciences Group identifies, develops and commercializes innovative nutraceutical products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically supported, GRAS-certified ingredients under its Swiss Research(TM) and Swiss Diet(TM) brand names. For more information, visit www.HSciences.com and www.Shugr.com. This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy, and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.